Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Thioglycolic Acid | HCID 1133 | — |
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | Lithium hydroxide, monohydrate | HCID 168937 | — |
| Reactant | HCID 86700671 | HCID 86700671 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 86700673 | HCID 86700673 | 69.7% |
Reaction Steps
A mixture of (2S,5R)-tert-butyl5-(N-(benzyloxy)-2-nitrophenylsulfonamido)-2-(1,2,4-oxadiazol-3-yl)piperidine-1-carboxylate (1.5 g, 2.683 mmol), HSCH2COOH (1.48 g, 16.1 mmol), LiOH.H2O (1.13 g, 26.83 mmol) in DMF (50 mL) was stirred at 30° C. for 17 hrs. EtOAc (150 mL) was then added and the mixture was washed with water (2×), and saturated sodium chloride (2×), dried over Na2SO4, and concentrated. The residue was purified by silica gel column chromatography (gradient elution 0˜50% petroleum ether/EtOAc) to give (2S,5R)-tert-butyl 5-(benzyloxyamino)-2-(1,2,4-oxadiazol-3-yl)piperidine-1-carboxylate (700 mg, 63%) as a pale yellow solid. ESI-MS (EI+, m/z): 375.0 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08916709B2 |
|---|
| Source dataset | uspto-grants-2014_12 |
|---|
| ORD ID | ord-56f0ae276ade4660b4a750af9b6df431 |
|---|
| Source note | uspto-grants-2014_12 |
|---|